Jiangsu Coben Pharmaceutical

Established in 2005, Coben Group was created and constructed in accordance with GMP standard covering a total area of 100,000 square meters. It is a part of ZJMI Group-Global Fortune 500, achieving the 270th position in 2018. Coben specializes in the research and production of APIs and intermediates for a variety of medications. Its primary products consist of Sofosbuvir, Tenofovir, Ticagrelor, Sacubitril, Voriconazole, Isavuconazole, and their respective intermediates.

Products & Services

PMPA, Sofosbuvir

Country

People's Republic of China

Show site details

Audit report appendices available

Audit report available

Jiangsu Coben Pharmaceutical

Country

People's Republic of China

City

Qidong, Jiangsu Province,

Address

Jiang Su Lu

This audit report also includes the following appended documentation:

Manufacturing license
Organization chart
Plant layout

Sacubitril

Sofosbuvir

Tenofovir

Ticagrelor

Sites